Skip to main content

Advertisement

Table 2 PFGE types of MRSA isolates included in the study and their respective antibiotic resistance profiles

From: Characterization of the clonal profile of methicillin resistant Staphylococcus aureus isolated from patients with early post-operative orthopedic implant based infections

PFGE clusters (no. of isolates) MRSA isolates Predominant antibiotic resistance profiles
A (2) MRSA 30, 5 CIP, LVX, ERY, CLI, CXM
B (4) MRSA 21, 47, 48, 40 CIP, AMC
C (3) MRSA 10, 12, 37 CIP, SXT, AMC, CXM
D (13) MRSA 19, 2, 20, 4, 34, 42, 43, 44, 14, 31, 33, 35, 36 ERY, GEN, AMC, CXM
E (3) MRSA 11, 41, 45 GEN, CXM
F (3) MRSA 49, 7, 8 ERY, CLI, SXT, GEN, AMC, CXM
G (2) MRSA 27, 28 CIP, LVX, SXT, AMK, GEN, AMC
H (3) MRSA 17, 9, 3 CIP, SXT
I (2) MRSA 23, 25 CIP, LVX, ERY, AMK, GEN, CXM
  1. Zones of inhibition falling into the category of intermediate susceptibility to a particular antibiotic were considered resistant
  2. Antimicrobial resistance patterns of MRSA from the laboratory. CIP ciprofloxacin, LVX levofloxacin, GEN gentamicin, ERY erythromycin, SXT trimethoprim–sulfamethoxazole, AMK amikacin, DOX doxycycline, CLI clindamycin, AMC amoxyclav, CXM cefuroxime